Terms: = Skin cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
510 results:
1. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
2. Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial.
Zhang D; Benedikt Westphalen C; Quante M; Waldschmidt DT; Held S; Kütting F; Dorman K; Heinrich K; Weiss L; Boukovala M; Haas M; Boeck S; Heinemann V; Probst V
Eur J Cancer; 2024 Apr; 201():113926. PubMed ID: 38401449
[TBL] [Abstract] [Full Text] [Related]
3. GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells.
Booth MR; Booth L; Roberts JL; West C; Dent P
Oncotarget; 2024 Feb; 15():124-133. PubMed ID: 38329728
[TBL] [Abstract] [Full Text] [Related]
4. CD4
Bawden EG; Wagner T; Schröder J; Effern M; Hinze D; Newland L; Attrill GH; Lee AR; Engel S; Freestone D; de Lima Moreira M; Gressier E; McBain N; Bachem A; Haque A; Dong R; Ferguson AL; Edwards JJ; Ferguson PM; Scolyer RA; Wilmott JS; Jewell CM; Brooks AG; Gyorki DE; Palendira U; Bedoui S; Waithman J; Hochheiser K; Hölzel M; Gebhardt T
Sci Immunol; 2024 Jan; 9(91):eadi9517. PubMed ID: 38241401
[TBL] [Abstract] [Full Text] [Related]
5. The effect of surgical timing in nonmetastatic melanoma.
Kakish H; Drigotas C; Ahmed FA; Elshami M; Bordeaux JS; Rothermel LD; Hoehn RS
J Surg Oncol; 2024 Mar; 129(3):509-516. PubMed ID: 37985362
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocol.
Fujimura T; Yoshino K; Nakamura M; Kato H; Ito T; Maekawa T; Fujisawa Y; Matsushita S; Amagai R; Yamazaki E; Takahashi M; Tamabuchi E; Hashimoto A; Kambayashi Y; Yamazaki N; Miyata T; Asano Y
Exp Dermatol; 2024 Jan; 33(1):e14976. PubMed ID: 37946551
[TBL] [Abstract] [Full Text] [Related]
7. Understanding choroidal nevus risk factors for transformation into melanoma.
DeSimone JD; Shields CN; Kalafatis NE; Marous MR; Marous CL; Shields JA; Shields CL
Clin Dermatol; 2024; 42(1):38-45. PubMed ID: 37866411
[TBL] [Abstract] [Full Text] [Related]
8. Digital spatial profiling of melanoma shows cd95 expression in immune cells is associated with resistance to immunotherapy.
Martinez-Morilla S; Moutafi M; Fernandez AI; Jessel S; Divakar P; Wong PF; Garcia-Milian R; Schalper KA; Kluger HM; Rimm DL
Oncoimmunology; 2023; 12(1):2260618. PubMed ID: 37781235
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic value of high-frequency ultrasound (HFUS) in evaluation of subcutaneous lesions.
Miao Y; Ren WW; Yang FY; Li L; Wu L; Dan Shan D; Chen ZT; Wang LF; Wang Q; Guo LH
Skin Res Technol; 2023 Sep; 29(9):e13464. PubMed ID: 37753674
[TBL] [Abstract] [Full Text] [Related]
10. Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL.
Tam C; Pinilla-Ibarz J; Castillo CG; Fenili AC; Huntley K; Karakus V; Mattar M; Miroli MA; Moura C; Pavlovsky M; Piotrowski F; Šimkovič M; Stilgenbauer S
Blood Adv; 2023 Nov; 7(22):6819-6828. PubMed ID: 37722356
[TBL] [Abstract] [Full Text] [Related]
11. Talin2 and KANK2 functionally interact to regulate microtubule dynamics, paclitaxel sensitivity and cell migration in the MDA-MB-435S melanoma cell line.
Lončarić M; Stojanović N; Rac-Justament A; Coopmans K; Majhen D; Humphries JD; Humphries MJ; Ambriović-Ristov A
Cell Mol Biol Lett; 2023 Jul; 28(1):56. PubMed ID: 37460977
[TBL] [Abstract] [Full Text] [Related]
12. Innovative integration of augmented reality and optical surface imaging: A coarse-to-precise system for radiotherapy positioning.
Zhang G; Jiang Z; Zhu J; Dai T; He X; Liu X; Chang Y; Wang L
Med Phys; 2023 Jul; 50(7):4505-4520. PubMed ID: 37060328
[TBL] [Abstract] [Full Text] [Related]
13. Carcinoid-Like Cell Arrangements in Basal Cell Carcinoma: A Study of 11 Cases.
Goto K; Oishi T; Yoshikawa S
Int J Surg Pathol; 2023 Dec; 31(8):1466-1472. PubMed ID: 36843540
[No Abstract] [Full Text] [Related]
14. Postoperative Echography for Optimization of Radiation Dosimetry in Patients with Uveal Melanoma Treated with Plaque Brachytherapy.
Binkley EM; King BA; Hyer DE; Javed A; Milhem MM; Hinz CJ; Mott SL; Boldt HC
Ophthalmol Retina; 2023 Jul; 7(7):620-627. PubMed ID: 36822323
[TBL] [Abstract] [Full Text] [Related]
15. Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
Obiorah IE; Karrs J; Brown L; Wang HW; Karai LJ; Pham TH; Pham TA; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):344-353. PubMed ID: 36598455
[TBL] [Abstract] [Full Text] [Related]
16. PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity.
Gu Y; Lin X; Dong Y; Wood G; Seidah NG; Werstuck G; Major P; Bonert M; Kapoor A; Tang D
J Exp Clin Cancer Res; 2023 Jan; 42(1):2. PubMed ID: 36588164
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of Human, Porcine, and Bovine Acellular Dermal Matrix in Prepectoral Breast Reconstruction: A Scoping Review.
Pires GR; Moss WD; Hosein RC; Overschmidt BT; Magno-Padron DA; Agarwal JP; McFarland MM; Casucci T; Kwok AC
Ann Plast Surg; 2022 Dec; 89(6):694-702. PubMed ID: 36416706
[TBL] [Abstract] [Full Text] [Related]
18. Cost-effectiveness of Response-Adapted De-escalation of Immunotherapy in Advanced Melanoma.
Cartun Z; Kunz WG; Heinzerling L; Tomsitz D; Guertler A; Westphalen CB; Ricke J; Weir W; Unterrainer M; Mehrens D
JAMA Dermatol; 2022 Dec; 158(12):1387-1393. PubMed ID: 36260321
[TBL] [Abstract] [Full Text] [Related]
19. PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma: A systematic review and meta-analysis.
He R; Zhao X; Liu J; Zhou Y; Zhang X; Cheng F
Medicine (Baltimore); 2022 Oct; 101(41):e30561. PubMed ID: 36254050
[TBL] [Abstract] [Full Text] [Related]
20. Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta-analysis.
He ZH; Qiu SC; Huang ZW; Zhang GQ; An QQ; Qu F; Wang N
Dermatol Ther; 2022 Dec; 35(12):e15928. PubMed ID: 36222320
[TBL] [Abstract] [Full Text] [Related]
[Next]
